{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:05:07Z","timestamp":1762866307533,"version":"3.40.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2334-13-570","type":"journal-article","created":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T01:27:05Z","timestamp":1386206825000},"source":"Crossref","is-referenced-by-count":30,"title":["Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA"],"prefix":"10.1186","volume":"13","author":[{"given":"Severin","family":"Gose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duylinh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniella","family":"Lowenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Pandori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,4]]},"reference":[{"key":"2762_CR1","first-page":"1","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","unstructured":"Centers for Disease Control and Prevention (CDC): Summary of notifiable diseases: United States, 2009. MMWR Morb Mortal Wkly Rep. 2011, 58: 1-100.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2762_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1056\/NEJMp1112456","volume":"366","author":"GA Bolan","year":"2012","unstructured":"Bolan GA, Sparling PF, Wasserheit JN: The Emerging Threat of Untreatable Gonococcal Infection. N Engl J Med. 2012, 366: 485-487. 10.1056\/NEJMp1112456.","journal-title":"N Engl J Med"},{"key":"2762_CR3","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s11908-011-0169-9","volume":"13","author":"RD Kirkcaldy","year":"2011","unstructured":"Kirkcaldy RD, Ballard RC, Dowell D: Gonococcal resistance: are cephalosporins next?. Curr Infect Dis Rep. 2011, 13: 196-204. 10.1007\/s11908-011-0169-9.","journal-title":"Curr Infect Dis Rep"},{"key":"2762_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/sti.2010.042648","volume":"86","author":"DA Lewis","year":"2010","unstructured":"Lewis DA: The Gonococcus fights back: is this time a knock out?. Sex Transm Infect. 2010, 86: 415-421. 10.1136\/sti.2010.042648.","journal-title":"Sex Transm Infect"},{"key":"2762_CR5","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1586\/eri.09.63","volume":"7","author":"JW Tapsall","year":"2009","unstructured":"Tapsall JW, Ndowa F, Lewis DA, Unemo M: Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther. 2009, 7: 821-834. 10.1586\/eri.09.63.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2762_CR6","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1111\/j.1749-6632.2011.06215.x","volume":"1230","author":"M Unemo","year":"2011","unstructured":"Unemo M, Shafer WM: Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future. Ann N Y Acad Sci. 2011, 1230: E19-E28. 10.1111\/j.1749-6632.2011.06215.x.","journal-title":"Ann N Y Acad Sci"},{"key":"2762_CR7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1517\/14656560902731993","volume":"10","author":"PM Barry","year":"2009","unstructured":"Barry PM, Klausner JD: The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother. 2009, 10: 555-577. 10.1517\/14656560902731993.","journal-title":"Expert Opin Pharmacother"},{"key":"2762_CR8","first-page":"1","volume":"59","author":"KA Workowski","year":"2010","unstructured":"Workowski KA, Berman S: Centers for Disease Control and Prevention (CDC): Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Cent Dis Control. 2010, 59: 1-110.","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Cent Dis Control"},{"key":"2762_CR9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1128\/AAC.00788-10","volume":"55","author":"VG Allen","year":"2011","unstructured":"Allen VG, Farrell DJ, Rebbapragada A, Tan J, Tijet N, Perusini SJ, Towns L, Lo S, Low DE, Melano RG: Molecular Analysis of Antimicrobial Resistance Mechanisms in Neisseria gonorrhoeae Isolates from Ontario, Canada. Antimicrob Agents Chemother. 2011, 55: 703-712. 10.1128\/AAC.00788-10.","journal-title":"Antimicrob Agents Chemother"},{"key":"2762_CR10","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1128\/AAC.46.12.3744-3749.2002","volume":"46","author":"S Ameyama","year":"2002","unstructured":"Ameyama S, Onodera S, Takahata M, Minami S, Maki N, Endo K, Goto H, Suzuki H, Oishi Y: Mosaic-Like Structure of Penicillin-Binding Protein 2 Gene (penA) in Clinical Isolates of Neisseria gonorrhoeae with Reduced Susceptibility to Cefixime. Antimicrob Agents Chemother. 2002, 46: 3744-3749. 10.1128\/AAC.46.12.3744-3749.2002.","journal-title":"Antimicrob Agents Chemother"},{"key":"2762_CR11","first-page":"19995","volume":"16","author":"MJ Cole","year":"2011","unstructured":"Cole MJ, Unemo M, Hoffmann S, Chisholm SA, Ison CA, van de Laar MJ: The European gonococcal antimicrobial surveillance programme, 2009. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2011, 16: 19995-","journal-title":"Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull"},{"key":"2762_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1136\/sti.2010.045377","volume":"86","author":"D Golparian","year":"2010","unstructured":"Golparian D, Hellmark B, Fredlund H, Unemo M: Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden. Sex Transm Infect. 2010, 86: 454-460. 10.1136\/sti.2010.045377.","journal-title":"Sex Transm Infect"},{"key":"2762_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1128\/AAC.49.1.137-143.2005","volume":"49","author":"M Ito","year":"2005","unstructured":"Ito M, Deguchi T, Mizutani K-S, Yasuda M, Yokoi S, Ito S-I, Takahashi Y, Ishihara S, Kawamura Y, Ezaki T: Emergence and Spread of Neisseria gonorrhoeae Clinical Isolates Harboring Mosaic-Like Structure of Penicillin-Binding Protein 2 in Central Japan. Antimicrob Agents Chemother. 2005, 49: 137-143. 10.1128\/AAC.49.1.137-143.2005.","journal-title":"Antimicrob Agents Chemother"},{"key":"2762_CR14","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1128\/AAC.01604-06","volume":"51","author":"R Lindberg","year":"2007","unstructured":"Lindberg R, Fredlund H, Nicholas R, Unemo M: Neisseria gonorrhoeae Isolates with Reduced Susceptibility to Cefixime and Ceftriaxone: Association with Genetic Polymorphisms in penA, mtrR, porB1b, and ponA. Antimicrob Agents Chemother. 2007, 51: 2117-2122. 10.1128\/AAC.01604-06.","journal-title":"Antimicrob Agents Chemother"},{"key":"2762_CR15","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/OLQ.0b013e31822c664f","volume":"38","author":"I Martin","year":"2011","unstructured":"Martin I, Jayaraman G, Wong T, Liu G, Gilmour M, Canadian Public Health Laboratory Network: Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000\u20132009. Sex Transm Dis. 2011, 38: 892-898. 10.1097\/OLQ.0b013e31822c664f.","journal-title":"Sex Transm Dis"},{"key":"2762_CR16","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/OLQ.0b013e3182401b69","volume":"39","author":"I Martin","year":"2012","unstructured":"Martin I, Sawatzky P, Allen V, Hoang L, Lefebvre B, Mina N, Wong T, Gilmour M: Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001\u20132010. Sex Transm Dis. 2012, 39: 316-323. 10.1097\/OLQ.0b013e3182401b69.","journal-title":"Sex Transm Dis"},{"key":"2762_CR17","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1128\/AAC.00325-11","volume":"55","author":"M Ohnishi","year":"2011","unstructured":"Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, Nakayama S, Kitawaki J, Unemo M: Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother. 2011, 55: 3538-3545. 10.1128\/AAC.00325-11.","journal-title":"Antimicrob Agents Chemother"},{"key":"2762_CR18","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1128\/AAC.00406-09","volume":"53","author":"M Pandori","year":"2009","unstructured":"Pandori M, Barry PM, Wu A, Ren A, Whittington WLH, Liska S, Klausner JD: Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California. Antimicrob Agents Chemother. 2009, 53: 4032-4034. 10.1128\/AAC.00406-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"2762_CR19","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3201\/eid1308.060948","volume":"13","author":"S Yokoi","year":"2007","unstructured":"Yokoi S, Deguchi T, Ozawa T, Yasuda M, Ito S, Kubota Y, Tamaki M, Maeda S: Threat to cefixime treatment for gonorrhea. Emerg Infect Dis. 2007, 13: 1275-1277.","journal-title":"Emerg Infect Dis"},{"key":"2762_CR20","first-page":"19833","volume":"16","author":"CA Ison","year":"2011","unstructured":"Ison CA, Hussey J, Sankar KN, Evans J, Alexander S: Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2011, 16: 19833-","journal-title":"Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull"},{"key":"2762_CR21","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1128\/AAC.00198-08","volume":"52","author":"JYC Lo","year":"2008","unstructured":"Lo JYC, Ho KM, Leung AOC, Tiu FST, Tsang GKL, Lo ACT, Tapsall JW: Ceftibuten Resistance and Treatment Failure of Neisseria gonorrhoeae Infection. Antimicrob Agents Chemother. 2008, 52: 3564-3567. 10.1128\/AAC.00198-08.","journal-title":"Antimicrob Agents Chemother"},{"key":"2762_CR22","first-page":"19792","volume":"16","author":"M Unemo","year":"2011","unstructured":"Unemo M, Golparian D, Hestner A: Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2011, 16: 19792-","journal-title":"Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull"},{"key":"2762_CR23","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1128\/AAC.05760-11","volume":"56","author":"M Unemo","year":"2012","unstructured":"Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P: High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012, 56: 1273-1280. 10.1128\/AAC.05760-11.","journal-title":"Antimicrob Agents Chemother"},{"key":"2762_CR24","first-page":"19998","volume":"16","author":"M Unemo","year":"2011","unstructured":"Unemo M, Golparian D, Stary A, Eigentler A: First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2011, 16: 19998-","journal-title":"Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull"},{"key":"2762_CR25","first-page":"19721","volume":"15","author":"M Unemo","year":"2010","unstructured":"Unemo M, Golparian D, Syversen G, Vestrheim DF, Moi H: Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2010, 15: 19721-","journal-title":"Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull"},{"key":"2762_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jama.2012.176575","volume":"309","author":"VG Allen","year":"2013","unstructured":"Allen VG, Mitterni L, Seah C, Rebbapragada A, Martin IE, Lee C, Siebert H, Towns L, Melano RG, Low DE: Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA J Am Med Assoc. 2013, 309: 163-170. 10.1001\/jama.2012.176575.","journal-title":"JAMA J Am Med Assoc"},{"key":"2762_CR27","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/jac\/dkt034","volume":"68","author":"DA Lewis","year":"2013","unstructured":"Lewis DA, Sriruttan C, M\u00fcller EE, Golparian D, Gumede L, Fick D, de Wet J, Maseko V, Coetzee J, Unemo M: Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. J Antimicrob Chemother. 2013, 68: 1267-1270. 10.1093\/jac\/dkt034.","journal-title":"J Antimicrob Chemother"},{"issue":"Pt 5","key":"2762_CR28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1099\/jmm.0.007641-0","volume":"58","author":"J Tapsall","year":"2009","unstructured":"Tapsall J, Read P, Carmody C, Bourne C, Ray S, Limnios A, Sloots T, Whiley D: Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. J Med Microbiol. 2009, 58 (Pt 5): 683-687.","journal-title":"J Med Microbiol"},{"key":"2762_CR29","first-page":"20200","volume":"17","author":"M Unemo","year":"2012","unstructured":"Unemo M, Golparian D, Poto\u010dnik M, Jeverica S: Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2012, 17: 20200-","journal-title":"Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull"},{"key":"2762_CR30","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/jac\/dks162","volume":"67","author":"J C\u00e1mara","year":"2012","unstructured":"C\u00e1mara J, Serra J, Ayats J, Bastida T, Carnicer-Pont D, Andreu A, Ardanuy C: Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother. 2012, 67: 1858-1860. 10.1093\/jac\/dks162.","journal-title":"J Antimicrob Chemother"},{"key":"2762_CR31","first-page":"20358","volume":"18","author":"SA Chisholm","year":"2013","unstructured":"Chisholm SA, Unemo M, Quaye N, Johansson E, Cole MJ, Ison CA, Van de Laar MJ: Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2013, 18: 20358-","journal-title":"Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull"},{"key":"2762_CR32","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1128\/AAC.01295-13","volume":"11","author":"K Shimuta","year":"2013","unstructured":"Shimuta K, Unemo M, Nakayama S-I, Morita-Ishihara T, Dorin M, Kawahata T, Ohnishi M, on behalf of the Antibiotic-Resistant Gonorrhea Study Group: Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan in 2010\u20132012 -- intensified surveillance after identification of the first high-level ceftriaxone resistant strain H041. Antimicrob Agents Chemother. 2013, 11: 5225-5232.","journal-title":"Antimicrob Agents Chemother"},{"key":"2762_CR33","first-page":"873","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","unstructured":"Centers for Disease Control and Prevention (CDC): Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000\u20132010. MMWR Morb Mortal Wkly Rep. 2011, 60: 873-877.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5 Pt 1","key":"2762_CR34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.7326\/0003-4819-158-5-201303050-00004","volume":"158","author":"RD Kirkcaldy","year":"2013","unstructured":"Kirkcaldy RD, Zaidi A, Hook EW, Holmes KH, Soge O, del Rio C, Hall G, Papp J, Bolan G, Weinstock HS: Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005\u20132010. Ann Intern Med. 2013, 158 (5 Pt 1): 321-328.","journal-title":"Ann Intern Med"},{"key":"2762_CR35","volume-title":"Gonorrhea - STD information from CDC [WWW Document]","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","unstructured":"Centers for Disease Control and Prevention (CDC): Gonorrhea - STD information from CDC [WWW Document]. 2010, URL http:\/\/www.cdc.gov\/std\/gisp\/ (accessed 11.14.13)"},{"key":"2762_CR36","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1128\/JCM.01800-07","volume":"46","author":"S Ochiai","year":"2008","unstructured":"Ochiai S, Ishiko H, Yasuda M, Deguchi T: Rapid detection of the mosaic structure of the Neisseria gonorrhoeae penA gene, which is associated with decreased susceptibilities to oral cephalosporins. J Clin Microbiol. 2008, 46: 1804-1810. 10.1128\/JCM.01800-07.","journal-title":"J Clin Microbiol"},{"key":"2762_CR37","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1128\/AAC.00626-06","volume":"50","author":"S Takahata","year":"2006","unstructured":"Takahata S, Senju N, Osaki Y, Yoshida T, Ida T: Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2006, 50: 3638-3645. 10.1128\/AAC.00626-06.","journal-title":"Antimicrob Agents Chemother"},{"key":"2762_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1748-720X.2005.tb00215.x","volume":"33","author":"JG Hodge","year":"2005","unstructured":"Hodge JG: An Enhanced Approach to Distinguishing Public Health Practice and Human Subjects Research. J Law Med Ethics. 2005, 33: 125-141. 10.1111\/j.1748-720X.2005.tb00215.x.","journal-title":"J Law Med Ethics"},{"key":"2762_CR39","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.mimet.2013.10.007","volume":"95","author":"S Gose","year":"2013","unstructured":"Gose S, Kong CJ, Lee Y, Samuel MC, Bauer HM, Dixon P, Soge OO, Lei J, Pandori M: Comparison of Neisseria gonorrhoeae MICs obtained by Etest and agar dilution for ceftriaxone, cefpodoxime, cefixime and azithromycin. J Microbiol Methods. 2013, 95: 379-380. 10.1016\/j.mimet.2013.10.007.","journal-title":"J Microbiol Methods"},{"key":"2762_CR40","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1086\/383047","volume":"189","author":"IMC Martin","year":"2004","unstructured":"Martin IMC, Ison CA, Aanensen DM, Fenton KA, Spratt BG: Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis. 2004, 189: 1497-1505. 10.1086\/383047.","journal-title":"J Infect Dis"},{"key":"2762_CR41","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2217\/fmb.12.117","volume":"7","author":"M Unemo","year":"2012","unstructured":"Unemo M, Nicholas RA: Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol. 2012, 7: 1401-1422. 10.2217\/fmb.12.117.","journal-title":"Future Microbiol"},{"key":"2762_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10156-008-0610-7","volume":"14","author":"K Osaka","year":"2008","unstructured":"Osaka K, Takakura T, Narukawa K, Takahata M, Endo K, Kiyota H, Onodera S: Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone. J Infect Chemother Off J Jpn Soc Chemother. 2008, 14: 195-203.","journal-title":"J Infect Chemother Off J Jpn Soc Chemother"},{"key":"2762_CR43","doi-asserted-by":"publisher","first-page":"5633","DOI":"10.1128\/AAC.00636-12","volume":"56","author":"D Hess","year":"2012","unstructured":"Hess D, Wu A, Golparian D, Esmaili S, Pandori W, Sena E, Klausner JD, Barry P, Unemo M, Pandori M: Genome sequencing of a Neisseria gonorrhoeae isolate of a successful international clone with decreased susceptibility and resistance to extended-spectrum cephalosporins. Antimicrob Agents Chemother. 2012, 56: 5633-5641. 10.1128\/AAC.00636-12.","journal-title":"Antimicrob Agents Chemother"},{"key":"2762_CR44","volume-title":"GISP Profiles","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","unstructured":"Centers for Disease Control and Prevention (CDC): GISP Profiles. 2011, [WWW Document], 2011. URL http:\/\/www.cdc.gov\/STd\/gisp2011\/figC.html (accessed 11.14.13), - Figure C. Percentage Of Gisp Participants Identifying As Men Who Have Sex With Men"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-570.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-13-570\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-570","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-570.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T01:53:00Z","timestamp":1746064380000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-13-570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2762"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-13-570","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2013,12]]},"article-number":"570"}}